학술논문

Mutations in cdsA and pgsA Correlate with Daptomycin Resistance in Streptococcus mitis and S. oralis.
Document Type
article
Source
Antimicrobial Agents and Chemotherapy. 63(2)
Subject
Biological Sciences
Biomedical and Clinical Sciences
Clinical Sciences
Anti-Bacterial Agents
Cardiolipins
Cell Membrane
Daptomycin
Drug Resistance
Bacterial
Humans
Microbial Sensitivity Tests
Nucleotidyltransferases
Phosphatidylglycerols
Streptococcus mitis
Streptococcus oralis
Transferases (Other Substituted Phosphate Groups)
CdsA
PgsA
daptomycin resistance
Streptococcus mitis
Microbiology
Medical Microbiology
Pharmacology and Pharmaceutical Sciences
Medical microbiology
Pharmacology and pharmaceutical sciences
Language
Abstract
We investigated the ability of several recent clinical viridans group streptococci (VGS) bloodstream isolates (Streptococcus mitis/S. oralis subgroup) from daptomycin (DAP)-naive patients to develop DAP resistance in vitro All strains rapidly developed high-level and stable DAP resistance. Substitutions in two enzymes involved in the cardiolipin biosynthesis pathway were identified, i.e., CdsA (phosphatidate cytidylyltransferase) and PgsA (CDP-diacylglycerol-glycerol-3-phosphate-3-phosphatidyltransferase). These mutations were associated with complete disappearance of phosphatidylglycerol and cardiolipin from cell membranes. DAP interactions with the cell membrane differed in isolates with PgsA versus CdsA substitutions.